I lead business development at Gelatex Technologies, where we use our HaloSpinning nanofiber platform to create drug delivery systems, wound care materials and Gelacell 3D cell culture tools. I focus on partnerships with pharma and biotech on controlled release, immune-competent in vitro models and regenerative medicine. Pharmacology / Toxicology Drug Delivery Tissue Engineering Expertise 3D Cell Culture Organoids / iPSC models Wound Healing Combination Products Intellectual Property / Patents